Gene · 3713
NIH grants1,524
NIH grants whose papers are about the gene, through NIH's grant-paper links.
801 to 820 of 1,524
Download this page as JSON| Grant | Title | IVL papers | Newest fiscal year |
|---|---|---|---|
| F32CA174146 | Role of Notch 1 signaling in esophageal carcinogenesis | 1 | 2015 |
| F32DE024685 | Contribution of G0-like Cells to Maintenance of the Oral Cancer Stem Cell Pool | 1 | 2015 |
| F32DK098877 | Three-dimensional Human Kidney Tissue System for Studying Renal Diseases | 1 | 2015 |
| F32HL116186 | Nutrient excess alters resolution of inflammation in diabetes and obesity | 1 | 2015 |
| I01RX000601 | Selective Hyaluronan Treatment to Overcome Age-related Epidermal Dysfunction | 1 | 2015 |
| K01AR062132 | Growth/differentiation control of keratinocytes by ROR alpha | 1 | 2015 |
| K08CA169865 | Integrated analysis of Notch pathway loss-of-function in epithelial tumorigenesis | 1 | 2015 |
| K08HD067295 | Defining Transition from Fetal to Adult T Cell Predominance in the Human Fetus | 1 | 2015 |
| K23AG037566 | Mechanisms of Spatial Cognitive Impairment in Neurodegenerative Disease | 1 | 2015 |
| K23AG038357 | Mechanisms and Treatment of Network Dysfunction in Alzheimer's Disease | 1 | 2015 |
| K23AG039414 | Detecting presymptomatic disease in inherited frontotemporal dementia | 1 | 2015 |
| KL2TR000151 | Transforming Translational Science and Education to Benefit Human Health | 1 | 2015 |
| P01CA025874 | Human Melanoma: Etiology, Progression and Therapy | 1 | 2015 |
| P01CA027502 | Chemoprevention of Skin Cancer Program Project | 1 | 2015 |
| P30AR061271 | Rheumatic Diseases Research Core Centers | 1 | 2015 |
| P30AR066527 | Duke Skin Disease Research Core Center | 1 | 2015 |
| P30DC011735 | Core Center for Chemical Senses | 1 | 2015 |
| P30ES000210 | Reducing Susceptibility to Environmental Stress Throughout the Life Span | 1 | 2015 |
| P50CA083639 | The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer | 1 | 2015 |
| P50GM076468 | Center for Genome Dynamics | 1 | 2015 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/grants?page=41